XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)   76,821,000      
Beginning balance (in shares) at Dec. 31, 2019 153,938,000        
Beginning balance at Dec. 31, 2019 $ 1,334,572        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock $ 371,522        
Ending balance (in shares) at Sep. 30, 2020 153,938,000        
Ending balance at Sep. 30, 2020 $ 1,706,094        
Beginning balance at Dec. 31, 2019 (1,122,721) $ 1 $ 0 $ 139 $ (1,122,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock (371,522)   (43,401)   (328,121)
Issuance of common stock upon exercise of stock options (in shares)   392,000      
Issuance of common stock upon exercise of stock options 121   121    
Stock-based compensation 43,280   43,280    
Unrealized (loss) gain on marketable securities 615     615  
Net loss (55,759)       (55,759)
Ending balance (in shares) at Sep. 30, 2020   77,213,000      
Ending balance at Sep. 30, 2020 $ (1,505,986) $ 1 0 754 (1,506,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)   76,857,000      
Beginning balance (in shares) at Jun. 30, 2020 153,938,000        
Beginning balance at Jun. 30, 2020 $ 1,436,736        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock $ 269,358        
Ending balance (in shares) at Sep. 30, 2020 153,938,000        
Ending balance at Sep. 30, 2020 $ 1,706,094        
Beginning balance at Jun. 30, 2020 (1,237,631) $ 1 0 1,248 (1,238,880)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock (269,358)   (110)   (269,248)
Issuance of common stock upon exercise of stock options (in shares)   356,000      
Issuance of common stock upon exercise of stock options 110 $ 0 110    
Unrealized (loss) gain on marketable securities (494)     (494)  
Net loss 1,387       1,387
Ending balance (in shares) at Sep. 30, 2020   77,213,000      
Ending balance at Sep. 30, 2020 $ (1,505,986) $ 1 0 754 (1,506,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)   77,213,000      
Beginning balance (in shares)   77,619,000      
Beginning balance (in shares) at Dec. 31, 2020 153,937,730        
Beginning balance at Dec. 31, 2020 $ 2,895,096        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock $ 2,646,662        
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) (153,938,000)        
Conversion of redeemable convertible preferred stock into common stock upon initial public offering $ (5,541,758)        
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Beginning balance at Dec. 31, 2020 (2,696,741) $ 1 0 411 (2,697,153)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock (2,646,662)   (2,264,869)   (381,793)
Conversion of redeemable convertible preferred stock (in shares)   153,938,000      
Conversion of redeemable convertible preferred stock into common stock upon initial public offering 5,541,758 $ 2 5,541,756    
Issuance of common stock upon initial public offering, net of underwriting discounts and offering expenses   31,350,000      
Issuance of common stock upon initial public offering, net of underwriting discounts and offering expenses $ 1,062,453   1,062,453    
Issuance of common stock upon exercise of stock options (in shares) 210,000 210,000      
Issuance of common stock upon exercise of stock options $ 43   43    
Stock-based compensation 124,717   124,717    
Unrealized (loss) gain on marketable securities (431)     (431)  
Net loss (117,259)       (117,259)
Ending balance (in shares) at Sep. 30, 2021   263,117,000      
Ending balance at Sep. 30, 2021 $ 1,267,878 $ 3 4,464,100 (20) (3,196,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)   77,756,000      
Beginning balance (in shares) at Jun. 30, 2021 153,938,000        
Beginning balance at Jun. 30, 2021 $ 3,276,920        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock $ 2,264,838        
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) (153,938,000)        
Conversion of redeemable convertible preferred stock into common stock upon initial public offering $ (5,541,758)        
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Beginning balance at Jun. 30, 2021 (3,088,791) $ 1 0 (2) (3,088,790)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of redeemable convertible preferred stock (2,264,838)   (2,264,838)   0
Conversion of redeemable convertible preferred stock (in shares)   153,938,000      
Conversion of redeemable convertible preferred stock into common stock upon initial public offering 5,541,758 $ 2 5,541,756    
Issuance of common stock upon initial public offering, net of underwriting discounts and offering expenses   31,350,000      
Issuance of common stock upon initial public offering, net of underwriting discounts and offering expenses 1,062,453   1,062,453    
Issuance of common stock upon exercise of stock options (in shares)   73,000      
Issuance of common stock upon exercise of stock options 12   12    
Stock-based compensation 124,717   124,717    
Unrealized (loss) gain on marketable securities (18)     (18)  
Net loss (107,415)       (107,415)
Ending balance (in shares) at Sep. 30, 2021   263,117,000      
Ending balance at Sep. 30, 2021 $ 1,267,878 $ 3 $ 4,464,100 $ (20) $ (3,196,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)   263,117,000